Vensica Medical

Company Overview

Snapshot

Founded in August 2014 by Avner Geva, Vensica Medical operates with 11–50 employees. The company has raised $33.2M across 6 funding rounds from 9 investors, with Israel Biotech Fund being a notable lead investor. In October 2024, Vensica Medical secured an $11M funding round to advance its Phase 2 trials for overactive bladder treatment.

Business overview

Vensica Medical is a urology therapeutics company developing ViXe, a product that combines Xeomin, a commercial neurotoxin, with Vibe, a needle-free, ultrasound drug delivery device. The Vibe platform is designed to deliver drugs directly into the bladder wall, providing uniform, controlled, and localized treatments for urology applications. It leverages disruptive ultrasound technology to microinject drugs through the natural barriers of the urinary bladder, serving the healthcare and life sciences sectors, particularly providers, with a focus on medical devices and medical treatment & therapeutics.

Strategic signal

In October 2024, Vensica Medical secured an $11 million funding round to support its Phase 2 trials for overactive bladder treatment. This capital infusion signals strong investor confidence in the company's innovative needle-free drug delivery system and its potential to address significant unmet needs in urology. The successful funding round positions Vensica Medical for critical clinical advancements, indicating a clear path toward commercialization and market disruption in the medical device and therapeutics space.

Company Intelligence Q&A

What was Vensica Medical's most recent funding round?

In October 2024, Vensica Medical secured an $11 million funding round, with. This funding is intended to support Phase 2 trials for overactive bladder treatment.

Which strategic partner invested in Vensica Medical in February 2022?

In February 2022, Vensica Medical closed a funding round with an investment from strategic partner Merz Therapeutics.

When did Vensica Medical close its $16 million investment round?

In November 2021, Vensica Medical closed a $16 million investment round with participation from.

What was the nature of the partnership launched in August 2021?

In August 2021, Merz and Israeli start-up Vensica Medical launched a partnership focused on the needleless treatment of overactive bladder.

Which company made a $2 million investment in Vensica Medical in September 2017?

In September 2017, Cogentix Medical made a $2 million investment in Vensica Medical, with Accelmed also participating.